Publication | Closed Access

Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP)

OncologyMedicineApoptosisCell DeathPathology5-Aza DcLiver CancerDna Methylation InhibitorPharmacologyHepatocellular Carcinoma